Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.

ABSTRACT:

SUBMITTER: Niyomnaitham S 

PROVIDER: S-EPMC9212727 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature